info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » therapeutics

therapeutics

Catheter Related Bloodstream Infection Market By Product Type (Antimicrobial Catheters, CHG Dressings, Needleless Connectors, Catheter Lock Solutions); By Pathogen Type (Gram-Positive Bacteria, Gram-Negative Bacteria, Fungal Pathogens); By End User (Hospitals, Dialysis Clinics, Infusion Centers, Home Healthcare Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Catheter-Related Bloodstream Infection (CRBSI) Market is projected to grow at a steady CAGR of 6.5%, reaching USD 2.35 billion by 2030 from USD 1.6 billion in 2024... Read More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Cardiac Amyloidosis Market By Product Type (Transthyretin Stabilizers, RNA Interference Therapies, Antisense Oligonucleotides, Monoclonal Antibodies, Diagnostics); By Application (Transthyretin Amyloidosis [Hereditary, Wild-type], Light Chain Amyloidosis); By End User (Hospitals, Specialty Cardiac Centers, Diagnostic Laboratories, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cardiac Amyloidosis Market will grow at a CAGR of 10.8% , valued at USD 4.2 billion in 2024 , and projected to reach USD 7.8 billion by 2030 , according t... Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

Cancer Anorexia Market By Product Type (Appetite Stimulants, Corticosteroids, Progestogens, Cannabinoids, Nutraceuticals, Biologics/Peptides); By Route of Administration (Oral, Injectable, Transdermal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cancer Anorexia Market valued at USD 2.9 billion in 2024 and expected to reach USD 4.3 billion by 2030, expanding with 6.8% CAGR, propelled by onc... Read More

Published Date: DEC-2025 | No Of Pages:185 | $ 4485

Bullous Keratopathy Market By Treatment Type (Corneal Transplantation [DMEK, DSAEK, Penetrating Keratoplasty], Pharmacological Therapy, Artificial Corneas, Supportive & Symptomatic Treatment); By Cause (Post-Cataract Surgery, Fuchs’ Dystrophy, Trauma, Infection, Congenital Disorders); By End User (Specialty Eye Hospitals, General Hospitals, ASCs, Academic/Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bullous Keratopathy Market is projected to grow steadily from USD 1.12 billion in 2024 to reach around USD 1.61 billion by 2030 , reflecting a CAG... Read More

Published Date: DEC-2025 | No Of Pages:157 | $ 4485

Bronchopulmonary Dysplasia (BPD) Treatment Market By Treatment Type (Caffeine Citrate Therapy, Pulmonary Surfactant Therapy, Corticosteroid Therapy, Diuretics, Bronchodilators, Pulmonary Vasodilators, Vitamin A Supplementation, Oxygen Therapy, Non-Invasive Respiratory Support, Mechanical Ventilation, Biologics and Growth-Factor Therapies, Cell-Based and Exosome Therapies); By Application (BPD Prevention in High-Risk Preterm Infants, Established Bronchopulmonary Dysplasia, Moderate-to-Severe Bronchopulmonary Dysplasia, Ventilator-Dependent Bronchopulmonary Dysplasia, BPD-Associated Pulmonary Hypertension, Post-Discharge Respiratory Management); By End User (Neonatal Intensive Care Units, Children’s Hospitals, Maternity and Perinatal Care Hospitals, Paediatric Pulmonology Clinics, Paediatric Cardiology Clinics, Specialty Neonatal Follow-Up Centres, Home Healthcare Providers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Bronchopulmonary Dysplasia Treatment Market: Negative Budesonide Trials Raise the Evidence Bar for Neonatal Biologics

The Global Bronchopulmonary Dysplasia (BPD) Treatment Market was valued at USD 1.30 billion in 2025 and is projected to reach ... Read More

Published Date: JUL-2026 | No Of Pages:195 | $ 4485

BRCA Mutations Treatment Market By Treatment Type (PARP Inhibitors, Hormonal Therapy, Chemotherapy, Targeted Combinations); By Cancer Type (Breast Cancer, Ovarian Cancer, Prostate Cancer, Pancreatic and Others); By End User (Hospitals and Cancer Centers, Specialty Oncology Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global BRCA Mutations Treatment Market is projected to reach a value of $5.8 billion in 2024 , with expectations to surpass $10.2 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:192 | $ 4485

Bone Metastasis Market By Treatment Type (Pharmaceuticals [Bisphosphonates, RANKL Inhibitors, Radiopharmaceuticals], Radiation Therapy, Surgical Interventions, Supportive Care); By Cancer Type (Breast Cancer, Prostate Cancer, Lung Cancer, Kidney Cancer, Thyroid & Others); By End User (Hospitals & Cancer Centers, Community Oncology Clinics, Specialty Orthopedic Centers, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bone Metastasis Market is expected to witness sustained growth, reaching USD 18.7 billion in 2024 and anticipated to cross USD 27.9 billion by 2030, reflecting a C... Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

Blepharitis Market By Disease Subtype (Posterior Blepharitis/Meibomian Gland Dysfunction, Demodex Blepharitis, Anterior Blepharitis, Mixed Blepharitis); By Treatment Type (Prescription Pharmaceuticals, Lid Hygiene Products, In-Office Procedures, Device-Based Home Therapies); By End User/Care Setting (Ophthalmology Clinics, Optometry Clinics, Hospitals, Home Care Users); By Distribution Channel (Retail Pharmacies & Drug Stores, Hospital Pharmacies, Online Platforms, Clinic-Based Dispensing); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Blepharitis Market: Disease-Specific Treatment Converts a Fragmented Care Category into Measurable Revenue

The Global Blepharitis Market is valued at USD 1.10 billion in 2025 and is projected to reach USD 1.67 billion by 2032, growing at a CAGR of 6.1%, according to S... Read More

Published Date: JUL-2026 | No Of Pages:150 | $ 4485

Biliary Atresia Market By Treatment Type (Surgical Interventions, Liver Transplantation, Pharmacological Therapies); By Diagnosis Stage (Early Diagnosis, Delayed Diagnosis); By End User (Tertiary Pediatric Hospitals, Specialty Liver Transplant Units, General Hospitals with Pediatric Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Biliary Atresia Market is projected to expand steadily between 2024 and 2030, driven by rising awareness of neonatal liver disorders, earlier diagnostic interventions, and ongoing advances... Read More

Published Date: DEC-2025 | No Of Pages:197 | $ 4485

Beta Thalassemia Market By Therapy Type (Blood Transfusions, Iron Chelation Therapy, Gene Therapy & Gene Editing, Bone Marrow/Stem Cell Transplantation); By Route of Administration (Intravenous, Oral); By End User (Hospitals & Hematology Centers, Specialty Clinics, Retail & Online Pharmacies, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Beta Thalassemia Market is projected to expand steadily between 2024 and 2030, valued at USD 1.9 billion in 2024 and expected to reach USD 3.1 billion by 2030, reflecting ... Read More

Published Date: DEC-2025 | No Of Pages:161 | $ 4485

Benign Prostatic Hyperplasia Treatment Market By Therapy Type (Pharmacological, Minimally Invasive Surgical Therapies, Surgical Procedures); By Procedure Setting (Hospitals, Ambulatory Surgical Centers, Urology Clinics); By End User (Hospitals & Teaching Institutions, Specialty Urology Centers, Retail & Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Benign Prostatic Hyperplasia Treatment Market: Generic Drug Volume, Procedure Durability, and Minimally Invasive Device Expansion Reshape Urology Competition

The Global Benign Prostatic Hyperplasia Treatment Market was valued at USD 12.4 billion in 2025 and is project... Read More

Published Date: JUL-2026 | No Of Pages:153 | $ 4485

AXL Receptor Tyrosine Kinase Inhibitors Market By Molecule Type (Small Molecule Inhibitors, Monoclonal Antibodies, Antibody-Drug Conjugates); By Application (Oncology, Fibrosis, Inflammatory Diseases); By Route of Administration (Oral, Intravenous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

AXL Inhibitors Market Advances as Oncology Pipelines Target Drug Resistance, Metastasis and Immune Evasion (Last Updated On: June-2026)

The Global AXL Receptor Tyrosine Kinase (RTK) Inhibitors Market valued at USD 1.2 billion in 2024 and set to reach USD 2.8 billion b... Read More

Published Date: DEC-2025 | No Of Pages:165 | $ 4485

Axial Spondyloarthritis Market By Treatment Type (TNF Inhibitors, IL-17 Inhibitors, JAK Inhibitors, NSAIDs, Conventional DMARDs, Other Therapies); By Disease Type (Radiographic Axial Spondyloarthritis, Non-Radiographic Axial Spondyloarthritis); By Route of Administration (Injectable, Oral, Intravenous); By End User (Hospitals, Rheumatology Clinics, Specialty Clinics, Homecare Settings); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Axial Spondyloarthritis Market: Earlier Diagnosis Expands Treatment Demand While Biosimilars Reset the Revenue Model

The Global Axial Spondyloarthritis (AxSpA) Market will experience consistent growth at a CAGR of 7.4%, increasing from USD 5.58 billion in 2025 to USD ... Read More

Published Date: JUL-2026 | No Of Pages:162 | $ 4485

Trodelvy Market By Indication (Triple-Negative Breast Cancer, HR+/HER2- Breast Cancer, Urothelial Carcinoma, Non-Small Cell Lung Cancer, Others); By Line of Therapy (Second-Line, Third-Line and Beyond, Maintenance); By Distribution Channel (Hospital Pharmacies, Oncology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Trodelvy Market valued at USD 1.62 billion in 2024 and anticipated to grow to USD 4.95 billion by 2030 at 20.1% CAGR, featuring Trodelvy marketRead More

Published Date: DEC-2025 | No Of Pages:193 | $ 4485

PIM Kinase Targeted Therapies Market By Therapy Type (Monotherapy, Combination Therapies); By Target Type (Selective PIM1 Inhibitors, Dual PIM/FLT3 Inhibitors, Pan-PIM Kinase Inhibitors); By Indication (Myelofibrosis, Aggressive B-Cell Lymphoma, Multiple Myeloma, Other Hematological Malignancies); By Development Stage (Clinical Stage Therapies, Preclinical Pipeline Candidates); By End User (Hospitals, Academic Cancer Centers, Specialty Oncology Clinics, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

PIM Kinase Targeted Therapies Market: Pipeline Progress Creates a New Specialist Oncology Opportunity

The Global PIM Kinase Targeted Therapies Market is estimated to reach USD 858.78 million in 2025 and is projected to ... Read More

Published Date: JUL-2026 | No Of Pages:196 | $ 4485

Lupus Nephritis Treatment Market By Drug Class (Immunosuppressants, Biologics, Corticosteroids, ACE Inhibitors & ARBs, Antimalarials); By Route of Administration (Oral, Intravenous, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lupus Nephritis Treatment Market is projected to grow at a CAGR of 10.4%, expanding from USD 1.6 billion in 2024 to approximately USD 2.9 billion ... Read More

Published Date: DEC-2025 | No Of Pages:165 | $ 4485

CD40 Targeted Therapies Market By Therapy Type (Monoclonal Antibodies, Fusion Proteins, Small Molecules); By Indication (Oncology, Autoimmune Diseases, Transplantation); By Route of Administration (Intravenous, Subcutaneous); By End User (Hospitals, Specialty Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD40 Targeted Therapies Market is projected to grow at a robust CAGR of 11.8%, reaching an estimated valuation of USD 3.9 billion by 2030... Read More

Published Date: DEC-2025 | No Of Pages:169 | $ 4485

Protein Misfolding & Aggregation Disorder Therapies (PMADT) Market By Target Protein (Amyloid-β, Tau, α-Synuclein, Huntingtin, TDP-43, Others); By Therapeutic Modality (Monoclonal Antibodies, RNA/Antisense Therapies, Small Molecule Modulators, Gene Therapy & Advanced Platforms); By Indication (Alzheimer’s, Parkinson’s, ALS, Huntington’s, Rare Proteinopathies); By Line of Therapy; By Region, Segment Revenue Estimation, Forecast, 2025–2035

1. Introduction and Strategic Context

The Global Protein Misfolding & Aggregation Disorder Therapies (PMADT) Market is projected to reach USD 1.7 billion by 2035, up from around USD 0.6 billion in 2025, growing at... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

PLK Targeted Therapies Market By Drug Type (PLK1 Inhibitors, Multi-Kinase Inhibitors); By Cancer Indication (Acute Myeloid Leukemia, Prostate Cancer, Ovarian Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Other Indications Led by Colorectal Cancer); By Treatment Line (First-Line Therapy, Second-Line Therapy, Maintenance and Combination Therapy); By Therapy Approach (Monotherapy, Combination Therapy, Biomarker-Guided Therapy); By End User (Hospitals, Specialty Oncology Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

PLK Targeted Therapies Market - Selective PLK Programs Move the Market Toward Its First Commercial Validation

The PLK targeted therapies market remains an emerging clinical-stage market rather than an established prescription category. No direct PLK inhibitor was iden... Read More

Published Date: JUL-2026 | No Of Pages:167 | $ 4485

Gamma Delta T Cell Cancer Therapy Market By Therapy Type (Allogeneic, Autologous); By Cancer Indication (Hematologic Malignancies, Solid Tumors); By Delivery Method (Non-Engineered, Genetically Modified); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gamma Delta T Cell Cancer Therapy Market valued at USD 318 million in 2024 and projected to reach USD 2.1 billion by 2030 at CAGR of 32.6%, combining Read More

Published Date: DEC-2025 | No Of Pages:163 | $ 4485

Cancer Photodynamic Therapy (PDT) Market By Product Type (Photosensitizing Agents, Light Delivery Systems); By Cancer Application (Lung Cancer, Esophageal Cancer, Bladder Cancer, Head & Neck Cancer, Skin Cancer, Others); By End User (Hospitals, Cancer Specialty Centers, Ambulatory Surgical Centers, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Cancer Photodynamic Therapy Market: Drug-Light Oncology Platform Shaped by Local Tumor Access and Precision Treatment (Last Updated on: June-2026)

The Global Cancer Photodynamic Therapy (PDT) Market is projected to grow at a CAGR of 8.9%, rising from USD 1.5 billion i... Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

CD5 Targeting Therapies Market By Therapy Type (Monoclonal Antibodies, Bispecific Antibodies, Antibody-Drug Conjugates, Small Molecule Inhibitors); By Indication (Hematologic Malignancies, Autoimmune Disorders, Graft-Versus-Host Disease); By End User (Hospitals and Cancer Centers, Academic and Research Institutes, Specialty Clinics, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD5 Targeting Therapies Market valued at USD 1.8 billion in 2024 and forecast to reach USD 3.6 billion by 2030 at 10.4%, CAGR, led by targeted the... Read More

Published Date: DEC-2025 | No Of Pages:199 | $ 4485

Trigeminal Neuralgia Treatment Market By Treatment Type (Pharmacological Therapy, Surgical Procedures, Non-Invasive Therapies); By Drug Class (Anticonvulsants, Muscle Relaxants, Antidepressants, Others); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Trigeminal Neuralgia Treatment Market is valued at USD 675 million in 2024 and projected to reach USD 1.02 billion by 2030, expanding at a 7.1% CAGR, driv... Read More

Published Date: DEC-2025 | No Of Pages:185 | $ 4485

DLL3 Targeted Therapies Market By Therapy Type (Antibody-Drug Conjugates, Bispecific Antibodies, Small Molecules, Cell Therapies); By Indication (Small Cell Lung Cancer, Large Cell Neuroendocrine Carcinoma, Other DLL3-Positive Tumors); By Route of Administration (Intravenous, Subcutaneous); By End User (Hospitals, Cancer Specialty Centers, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global DLL3 Targeted Therapies Market is valued at USD 472.5 million in 2024 and projected to reach USD 1.34 billion by 2030, growing at a robust 18.9% CAGR, dri... Read More

Published Date: DEC-2025 | No Of Pages:168 | $ 4485

CD123 Targeted Therapy Market By Therapy Type (Antibody-Drug Conjugates, Monoclonal Antibodies, Bispecific Antibodies, CAR-T Therapies); By Application (Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, Myelodysplastic Syndromes, Others); By End User (Academic & Research Hospitals, Cancer Specialty Centers, Community Hospitals & Clinics, CROs & Trial Sites); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD123 Targeted Therapy Market is projected to grow from USD 2.1 billion in 2024 to USD 5.3 billion by 2030, registering a strong 16.7% CAGR, driven b... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Targeted Alpha Therapy Market By Isotope Type (Actinium-225, Thorium-227, Bismuth-213, Others); By Therapeutic Area (Prostate Cancer, Leukemia, Glioblastoma, Neuroendocrine Tumors, Others); By End User (Academic Cancer Centers, Oncology Hospitals, Radiopharmacies & Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Targeted Alpha Therapy Market is projected to grow at a strong 20.8% CAGR, increasing from USD 1.34 billion in 2024 to USD 4.12 billion by 2030, driven by... Read More

Published Date: DEC-2025 | No Of Pages:172 | $ 4485

CD70 Targeting Therapies Market By Therapy Type (Monoclonal Antibodies, Antibody-Drug Conjugates, CAR-T Cell Therapy, Bispecific Antibodies); By Indication (Renal Cell Carcinoma, Lymphomas, Acute Myeloid Leukemia, Others); By Route of Administration (Intravenous, Subcutaneous); By End User (Hospitals, Specialty Clinics, Academic & Research Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD70 Targeting Therapies Market is projected to grow at a strong CAGR of 17.4%, rising from USD 1.2 billion in 2024 to USD 3.1 billion by 2030, fueled by ... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

Dysmenorrhea Treatment Market By Treatment Type (NSAIDs, Hormonal Therapy, Complementary Therapies, Surgical Intervention); By Route of Administration (Oral, Injectable, Transdermal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dysmenorrhea Treatment Market is projected to grow from USD 6.8 billion in 2024 to USD 10.1 billion by 2030, expanding at a 6.8% CAGR, driven by rising diagnosis rates, ho... Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

Fecal Microbiota Transplants (FMT) Market By Product Type (Traditional Fecal Suspensions, Processed Microbiota Formulations); By Route of Administration (Colonoscopy, Enema, Nasogastric/Nasoduodenal Tube, Oral Capsules); By End User (Hospitals, Specialty Clinics, Research Institutes, Stool Banks); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Fecal Microbiota Transplants (FMT) Market is poised to witness a robust CAGR of approximately 1... Read More

Published Date: DEC-2025 | No Of Pages:191 | $ 4485

B-Cell Maturation Antigen (BCMA) Targeted Therapies Market By Therapy Type (CAR-T Cell Therapy, Bispecific Antibodies, Antibody-Drug Conjugates); By Indication (Multiple Myeloma, Lymphoma, Other B-cell Malignancies); By Line of Therapy (Third-line and Beyond, Earlier-line Settings); By End User (Academic Hospitals, Community Oncology Centers, Specialty Infusion Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market is projected to expand at a... Read More

Published Date: DEC-2025 | No Of Pages:182 | $ 4485

Autosomal Dominant Polycystic Kidney Disease Market By Drug Class (Vasopressin V2 Receptor Antagonists, Somatostatin Analogs, mTOR Inhibitors, Anti-Inflammatory & Antifibrotic Agents); By Diagnostic & Monitoring Tools (MRI/CT Imaging, Genetic Testing, Biomarker Platforms); By End User (Nephrology Clinics, Specialty Hospitals, Diagnostic/Imaging Centers, Digital Health & Home Monitoring Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Autosomal Dominant Polycystic Kidney Disease (ADPKD) Market is projected to grow from $2.7 billion in 2024 to $3.8 billion by 2030 at a 5.9% CAGR, driven ... Read More

Published Date: DEC-2025 | No Of Pages:188 | $ 4485

Autosomal Dominant Optic Atrophy Market By Treatment Type (Gene Therapy, Supportive & Neuroprotective Therapies); By Diagnosis Stage (Early-Stage Diagnosis, Late-Stage Diagnosis); By End User (Academic Hospitals, Ophthalmology Clinics, Genetic Testing Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Autosomal Dominant Optic Atrophy Market valued at USD 143 million in 2024 and projected to reach USD 248 million by 2030 at 9.6%, CAGR, featuring ... Read More

Published Date: DEC-2025 | No Of Pages:161 | $ 4485

Autoimmune Encephalitis Treatment Market By Treatment Type (Acute Immunotherapy, Maintenance Immunotherapy, Adjunctive Care); By Antibody Subtype (Anti-NMDA, LGI1, CASPR2, GABA, AMPA, Others); By End User (Tertiary Hospitals, General Hospitals, Neurology Clinics, Pediatric Centers, Infusion Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Autoimmune Encephalitis Treatment Market is projected to grow at a robust CAGR of 8.1% , with an estimated value of USD 3.2 billion in 2024 and expected to reach U... Read More

Published Date: DEC-2025 | No Of Pages:188 | $ 4485

Atrophic Vaginitis Treatment Market By Treatment Type (Local Vaginal Estrogen [Creams & Gels, Tablets & Soft-Gel Inserts, Vaginal Rings], Vaginal Prasterone, Oral SERM Therapy [Ospemifene], Systemic Hormone Therapy, Nonhormonal Therapy [Moisturizers, Lubricants, Hyaluronic Acid Products]); By Route of Administration (Vaginal / Topical, Oral, Systemic); By Distribution Channel (Retail Pharmacies & Drug Stores, Online Pharmacies & Telehealth Platforms, Hospital Pharmacies); By Geography, Segment Revenue Estimation and Forecast, 2026–2032

Atrophic Vaginitis Treatment Market: Low Prescription Conversion Is Reshaping Local Estrogen and Hormone-Free Therapy

The Global Atrophic Vaginitis Treatment Market was valued at USD 3.62 billion in 2025 and is projected to reach USD 5.98 billion by 2032, growing at a... Read More

Published Date: JUL-2026 | No Of Pages:181 | $ 4485

Astrocytoma Market By Grade (Low-Grade [Grade I & II], High-Grade [Grade III & IV]); By Treatment (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy); By End User (Hospitals, Oncology Centers, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Astrocytoma Market is projected to grow from USD 2.1 billion in 2024 to USD 3.0 billion by 2030 at a 5.8% CAGR, driven by advances in neurosurgery, molecu... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Angioimmunoblastic T-cell Lymphoma Market By Therapy Type (Chemotherapy Regimens, Targeted Therapies, Monoclonal Antibodies & Biologics, Stem Cell Transplant); By Line of Therapy (First-Line, Second-Line and Beyond); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Angioimmunoblastic T -Cell Lymphoma Market is projected to expand at a CAGR of 8.1% , moving from an es... Read More

Published Date: DEC-2025 | No Of Pages:163 | $ 4485

Aneurysmal Subarachnoid Hemorrhage Market By Treatment Type (Endovascular Coiling, Surgical Clipping, Pharmacologic Therapy); By Drug Class (Calcium Channel Blockers, Vasodilators, Endothelin Receptor Antagonists, Neuroprotective Agents); By End User (Tertiary Stroke Centers, General Hospitals, Academic Medical Centers, Ambulatory Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aneurysmal Subarachnoid Hemorrhage Market is estimated to be worth USD 1.74 billion in 2024 , and it's projected to reach around Read More

Published Date: DEC-2025 | No Of Pages:156 | $ 4485

ANCA Associated Vasculitis Market By Disease Type (Granulomatosis with Polyangiitis, Microscopic Polyangiitis, Eosinophilic Granulomatosis with Polyangiitis); By Treatment Class (Corticosteroids, Immunosuppressants, Biologic Therapies, Plasma Exchange & Adjunct Therapies); By Route of Administration (Oral, IV, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global ANCA Associated Vasculitis (AAV) Market is forecast to expand steadily, with an inferred CAGR of 6.1% , valued at roughly USD 1.6 billion in 2024 and proj... Read More

Published Date: DEC-2025 | No Of Pages:189 | $ 4485

Alport Syndrome Market By Product Type (Pharmacological Therapies, Gene and Cell Therapies, Supportive Care); By Route of Administration (Oral, Intravenous, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Alport Syndrome Market is projected to grow from USD 412 million in 2024 to nearly USD 615 million by 2030 at a 6.8% CAGR, driven by advances in genetic t... Read More

Published Date: DEC-2025 | No Of Pages:188 | $ 4485

Alpha-1 Antitrypsin Deficiency Market By Therapy Type (Augmentation Therapy, Gene Therapy, Small Molecule Drugs); By Route of Administration (Intravenous, Inhalation, Subcutaneous); By Disease Manifestation (Pulmonary, Liver, Others); By End User (Hospitals, Specialty Clinics, Home Infusion Services, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Alpha-1 Antitrypsin Deficiency Market valued at USD 2.8 billion in 2024 and forecast to reach USD 4.1 billion by 2030 at 6.3%, CAGR, strengthened by Read More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Alpha Thalassemia Treatment Market By Treatment Type (Blood Transfusions & Supportive Care, Iron Chelation Therapy, Oral Targeted Therapy, Stem Cell Transplantation, Gene & Cell Therapy); By Disease Type (Hemoglobin H Disease, Alpha Thalassemia Major/Hb Bart’s Hydrops Fetalis, Other Symptomatic Alpha Thalassemia); By Route of Administration (Oral, Parenteral, Transfusion-Based); By Distribution Channel (Hospitals & Transfusion Centers, Specialty Pharmacies, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Alpha Thalassemia Treatment Market: Oral Therapy Expands a Transfusion-Led Care Model

The Global Alpha Thalassemia Treatment Market was valued at USD 1.19 billion in 2025 and is projected to reach USD 1.94 billion by 2032, growing at a CAGR of 7.3%, according to Strat... Read More

Published Date: JUL-2026 | No Of Pages:200 | $ 4485

Alopecia Areata Market By Treatment Type (Pharmaceutical Treatments [JAK Inhibitors, Corticosteroids, Conventional Immunosuppressants, Topical Immunotherapy, Minoxidil and Other Adjunctive Treatments], Procedure-Based Treatments [Intralesional Corticosteroid Injections, Phototherapy and Excimer Laser Therapy, Platelet-Rich Plasma Therapy]); By Route of Administration (Oral, Topical, Injectable); By Disease Type (Patchy Alopecia Areata, Alopecia Totalis, Alopecia Universalis, Ophiasis and Other Severe Patterns); By Patient Group (Adults, Adolescents, Pediatric Patients); By End User (Dermatology Clinics, Hospitals, Specialty Hair-Loss Treatment Centres, Homecare Settings); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Alopecia Areata Market: Severe-Disease Treatment and Formulary Access Drive Revenue Growth

The Global Alopecia Areata Market was valued at USD 3.45 billion in 2025 and is projected to reach USD 5.84 billion by 2032, expanding at a CAGR of 7.8%... Read More

Published Date: JUL-2026 | No Of Pages:185 | $ 4485

Alagille Syndrome Market By Treatment Type (Pharmacological Therapies, Surgical Interventions, Supportive Therapies); By Route of Administration (Oral, Parenteral/Hospital-Based); By End User (Hospitals & Specialty Centers, Diagnostic Laboratories, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Alagille Syndrome Market is projected to grow at a 7.5% CAGR, rising from USD 0.46 billion in 2024 to nearly USD 0.76 billion by 2030, driven by Read More

Published Date: DEC-2025 | No Of Pages:170 | $ 4485

Age Related Vision Dysfunction Market By Disorder Type (AMD, Cataracts, Glaucoma, Diabetic Retinopathy, Presbyopia); By Treatment Modality (Pharmacological, Surgical, Assistive Technologies, Diagnostic Imaging); By End User (Ophthalmology Clinics, Hospitals & ASCs, Retail Optometry Chains, Home-Based Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Age-Related Vision Dysfunction Market valued at USD 23.5 billion in 2024 and projected to reach USD 35.1 billion by 2030 at 6.8%, CAGR, driven by ... Read More

Published Date: DEC-2025 | No Of Pages:197 | $ 4485

Advanced Renal Cell Carcinoma Market By Therapy Class (Tyrosine Kinase Inhibitors, mTOR Inhibitors, Immune Checkpoint Inhibitors, HIF-2α Inhibitors, Bispecifics and Others); By Line of Treatment (First-Line, Second-Line, Later Lines); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Retail & Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Advanced Renal Cell Carcinoma Market is projected to grow at a 7.8% CAGR, increasing from USD 9.6 billion in 2024 to USD 15.1 billion by 2030, driven by e... Read More

Published Date: DEC-2025 | No Of Pages:187 | $ 4485

Adrenal Crisis Management Market By Product Type (Corticosteroid Injections, Auto-injectors & Prefilled Syringes, Oral Corticosteroids & Adjunct Therapies); By Route of Administration (Intravenous, Intramuscular / Subcutaneous); By End User (Hospitals & Emergency Departments, Ambulatory Clinics, Homecare, EMS Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Adrenal Crisis Management Market is projected to expand steadily, with an inferred CAGR of 6.1% , rising from an estimated USD 3.2 billion in 2024 to arou... Read More

Published Date: DEC-2025 | No Of Pages:157 | $ 4485

Acute Respiratory Distress Syndrome Treatment Market By Treatment Modality (Mechanical Ventilation, Oxygen Therapy and High-Flow Nasal Oxygen, Prone-Positioning and Supportive Care, Fluid Management, VV-ECMO, Pharmacotherapy, Investigational Biologics and Cell-Derived Therapies); By Drug Class (Corticosteroids, Anti-Infective Agents, Sedatives and Analgesics, Neuromuscular Blocking Agents, Loop Diuretics, Vasopressors, Anticoagulants, Other Supportive Medicines); By ARDS Severity (Mild ARDS, Moderate ARDS, Severe ARDS); By Etiology (Pneumonia-Associated ARDS, Sepsis-Associated ARDS, Aspiration-Associated ARDS, Trauma-Associated ARDS, Transfusion-Associated ARDS, Pancreatitis-Associated ARDS, Burns and Inhalational Injury-Associated ARDS, Other Causes); By End User (Hospitals and Intensive Care Units, Tertiary and Academic Medical Centers, Specialty Pulmonary and Critical-Care Centers, ECMO and Advanced Respiratory-Support Centers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Acute Respiratory Distress Syndrome (ARDS) Treatment Market

Critical-Care Infrastructure Defines the Market

The Global Acute Respiratory Distress Syndrome Treatment Market was valued at USD 3.32 billion in 2025 and is projected to reach US... Read More

Published Date: Aug-2026 | No Of Pages:198 | $ 4485

Acute Pancreatitis Market By Treatment Type (Supportive Care, Pharmacotherapy, Interventional & Surgical Procedures); By Etiology (Gallstone-Induced, Alcohol-Induced, Hypertriglyceridemia-Induced, Other/Idiopathic); By End User (Hospitals, Specialty Gastroenterology Centers, Ambulatory Surgical Centers, Long-Term Care Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute Pancreatitis Market with 6.7% CAGR, expanding from USD 5.8 billion in 2024 to USD 8.6 billion by 2030, driven by acute pancreatitis market g... Read More

Published Date: DEC-2025 | No Of Pages:192 | $ 4485

Acute on Chronic Liver Failure Market By Treatment Type (Pharmacological Therapy, Liver Support Systems, Organ Transplantation, Plasma Exchange); By End User (Tertiary Care Hospitals, Transplant Centers, Academic Medical Institutions, Specialty Liver Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute on Chronic Liver Failure ( ACLF ) Market is expected to grow at a CAGR of 9.0% , with a total valuation of approxi... Read More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Acute Ocular Pain Market By Treatment Type (Topical NSAIDs, Topical Corticosteroids, Local Anesthetics, Neuropathic Pain Agents, Biologics); By Indication (Post-Operative Eye Pain, Corneal Abrasions & Injuries, Uveitis & Inflammatory Episodes, Chemical Burns, Neuropathic Ocular Pain); By Route of Administration (Topical Drops, Injectables, Oral Medications, Ocular Implants/Inserts); By End User (Ophthalmology Clinics, Hospital Emergency Departments, Ambulatory Surgical Centers, Retail Pharmacies, Teleophthalmology Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute Ocular Pain Market to grow from USD 2.1 billion in 2024 to USD 3.1 billion by 2030 at a 6.4% CAGR, driven by rising ophthalmic surgeries, post-opera... Read More

Published Date: DEC-2025 | No Of Pages:195 | $ 4485

Acute Gout Flare Therapeutics Market By Drug Class (NSAIDs, Colchicine, Corticosteroids, Biologic / IL-1-Targeted Agents, Other Acute Agents); By Route of Administration (Oral, Injectable); By Geography (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2026–2032

Acute Gout Flare Therapeutics Market

Research Description | Market Intelligence, Competitive Dynamics and 2026 Pipeline Update

Prepared by Strategic Market Research  |  Last substantively reviewed: 25 Augus... Read More

Published Date: DEC-2025 | No Of Pages:171 | $ 4485

Acute Coronary Syndrome Market By Type (STEMI, NSTEMI, Unstable Angina); By Drug Class (Antiplatelet Agents, Anticoagulants, Statins, Beta-Blockers, ACE Inhibitors/ARBs, Thrombolytics); By Device Type (Coronary Stents, Balloon Catheters, IVUS/OCT Imaging, Thrombectomy Devices, Diagnostics); By End User (Hospitals with PCI Facilities, EMS, Secondary Hospitals, Cardiology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute Coronary Syndrome Market is projected to grow from USD 11.2 billion in 2024 to USD 16.7 billion by 2030 at a 6.8% CAGR, driven by rising cardiovascu... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market By Drug Class (Oxazolidinones, Lipoglycopeptides, Lipopeptides, Beta-lactams & Cephalosporins, Others); By Route of Administration (Intravenous, Oral, Long-Acting Injectable); By Infection Type (Cellulitis, Wounds, Abscesses, Trauma); By End User (Hospitals, ASCs, Outpatient Clinics, Home Healthcare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute Bacterial Skin and Skin Structure Infections Market is projected to expand steadily, valued at approximately USD 5.8 billion in 2024Read More

Published Date: DEC-2025 | No Of Pages:155 | $ 4485

Acid Sphingomyelinase Deficiency (ASMD) Market By Product Type (Enzyme Replacement Therapy, Gene Therapy Candidates, Supportive Care); By Application (Type A – Infantile Neurovisceral, Type B – Chronic Visceral, Type A/B Intermediate); By End User (Specialty & Tertiary Hospitals, Academic & Research Institutes, Home Infusion & Specialty Pharmacies, General Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acid Sphingomyelinase Deficiency Market will witness a strong growth trajectory, valued at USD 450 million in 2024 and projected to reach approximately Read More

Published Date: DEC-2025 | No Of Pages:170 | $ 4485

Achondroplasia Market By Therapy Type (CNP Analogs, FGFR Inhibitors, Adjunctive & Supportive Care); By Patient Age Group (Pediatrics, Adults); By Route of Administration (Subcutaneous Injections, Oral Therapies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Achondroplasia Market will expand steadily between 2024 and 2030, with the market estimated at USD 1.1 billion in 2024 and projected to reach around USD 2.4 billio... Read More

Published Date: DEC-2025 | No Of Pages:199 | $ 4485

LAG-3 Targeting Therapy Market By Therapy Type (Monotherapy, Combination Therapy); By Indication (Melanoma, Non-Small Cell Lung Cancer, Triple-Negative Breast Cancer, Head & Neck Squamous Cell Carcinoma, Other Solid Tumors, Hematologic Malignancies); By End User (Hospitals, Specialty Cancer Centers, Academic Research Institutes, Clinical Trial Sites); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global LAG-3 Targeting Therapy Market valued at USD 1.37 billion in 2024 and projected to exceed USD 5.1 billion by 2030 at 24.1% CAGR, highlighting tumo... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

PRMT5 Targeted Therapies Market By Drug Type (Small Molecule Inhibitors, Allosteric Inhibitors, Protein Degraders); By Application (NSCLC, Glioblastoma, Pancreatic Cancer, Mantle Cell Lymphoma, AML, MDS); By Route of Administration (Oral, Intravenous); By End User (Academic Cancer Centers, Oncology Clinics, Community Hospitals, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global PRMT5 Targeted Therapies Market is poised to expand at a robust CAGR of 28.4%, valued at approximately USD 412 million in 2024, and proje... Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

CD39 Targeted Therapies Market By Therapy Type (Monoclonal Antibodies, Bispecific Antibodies, Small-Molecule Inhibitors); By Cancer Indication (Non-Small Cell Lung Cancer, Pancreatic Cancer, Gastrointestinal Stromal Tumors, Desmoid Tumors, Other Solid Tumors); By Treatment Approach (Monotherapy, Combination Immunotherapy, Combination Chemotherapy, Perioperative Therapy); By End User (Hospitals, Specialty Cancer Centers, Research Institutes, Clinical Trial Centers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

CD39 Targeted Therapies Market: Biomarker Validation and Randomized Evidence Define the Commercial Race

The Global CD39 Targeted Therapies Market is estimated to reach USD 498.54 million in 2025 and is projected to grow... Read More

Published Date: JUL-2026 | No Of Pages:157 | $ 4485

Biotherapeutics Market By Product Type (Monoclonal Antibodies, Recombinant Proteins, Cell Therapy Products, Gene Therapies, Vaccines); By Application (Oncology, Autoimmune Diseases, Rare Genetic Disorders, Infectious Diseases, Neurological Disorders); By Route of Administration (Intravenous, Subcutaneous, Oral & Others); By End User (Academic & Specialty Hospitals, General Hospitals, Infusion Clinics, Specialty Pharmacies & Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Biotherapeutics Market is projected to grow from USD 356.7 billion in 2024 to nearly USD 587.2 billion by 2030 at a steady 8.6% CAGR, driven by advances i... Read More

Published Date: DEC-2025 | No Of Pages:193 | $ 4485

Hormonal Contraceptives Market By Product Type (Combined Hormonal Contraceptives, Progestin-Only Contraceptives); By Route of Administration (Oral, Transdermal, Subdermal, Intramuscular, Vaginal); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hormonal Contraceptives Market is projected to grow from $21.3 billion in 2024 to $29.7 billion by 2030, expanding at a 5.7% CAGR, driven by rising LARC a... Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

Tumor Infiltrating Lymphocytes (TILs) Market By Therapy Type (Autologous TILs, Genetically Modified TILs); By Indication (Melanoma, NSCLC, Cervical Cancer, Head & Neck Cancer, Others); By Manufacturing Model (Centralized, Decentralized); By End User (Academic Centers, Oncology Hospitals, Cell Therapy Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Tumor Infiltrating Lymphocytes (TILs) Market is projected to reach USD 1.26 billion in 2024 and grow to USD 3.47 billion by 2030 at a robust 18.5% CAGR, d... Read More

Published Date: DEC-2025 | No Of Pages:174 | $ 4485

Venous Thromboembolism (VTE) Treatment Market By Product Type (Anticoagulants, Thrombolytic Agents, Mechanical Thrombectomy Devices, Vena Cava Filters); By Route of Administration (Oral, Injectable, Intravenous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Venous Thromboembolism (VTE) Treatment Market is projected to grow at a steady 6.5% CAGR, rising from USD 10.8 billion in 2024 to nearly USD 16.5 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:175 | $ 4485

Mitochondrial Disease Therapies Market By Therapy Type (Small Molecules, Gene Therapy, Enzyme Replacement, Others); By Route of Administration (Oral, Injectable/Intravenous, Others); By End User (Hospitals, Specialty Clinics, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Mitochondrial Disease Therapies Market will expand steadily at an CAGR of 9.1%, valued at USD 1.1 billion in 2024, and projected to reach USD 2.0 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:188 | $ 4485

Pulmonary Embolism Therapeutics Market By Drug Class (DOACs, LMWH, Unfractionated Heparin, Vitamin K Antagonists, Thrombolytics); By Route of Administration (Oral, Injectable); By Disease Severity (Low-Risk, Submassive, Massive); By End User (Hospitals, Specialty Clinics, Retail Pharmacies, Home Healthcare Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pulmonary Embolism Therapeutics Market is projected to grow at a CAGR of 6.3% , valued at USD 2.7 billion in 2024 and anticipated to reach approximately USD 4.1 bi... Read More

Published Date: DEC-2025 | No Of Pages:155 | $ 4485

Dimpleplasty Market By Procedure Type (Suturing Technique, Excisional Technique); By Gender (Male, Female); By Age Group (18–25, 26–35, 36–50, 50+); By End User (Cosmetic Surgery Clinics, Aesthetic Dermatology Practices, Hospital-Based Cosmetic Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Dimpleplasty Market growing at 9.6% CAGR, expanding from USD 74.6 million in 2024 to USD 128.4 million by 2030, driven by cosmetic surgeryRead More

Published Date: DEC-2025 | No Of Pages:172 | $ 4485

Brachioplasty Market By Technique (Traditional Brachioplasty, Mini Brachioplasty, Extended Brachioplasty, Non-Invasive Techniques); By Gender (Male, Female); By End User (Hospitals, Ambulatory Surgical Centers, Aesthetic Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Brachioplasty Market growing at 8.2%, CAGR, advancing from USD 1.3 billion in 2024 to USD 2.1 billion by 2030, with rising cosmetic surgery trends... Read More

Published Date: DEC-2025 | No Of Pages:173 | $ 4485

Neoantigen Targeted Therapy Market By Therapy Type (Personalized Neoantigen Vaccines, T-cell Based Therapies); By Cancer Indication (Melanoma, NSCLC, Glioblastoma, Bladder Cancer, Colorectal Cancer, Others); By Delivery Platform (mRNA, Peptide, Dendritic Cell, DNA-based); By End User (Academic Medical Centers, Specialty Cancer Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Neoantigen Targeted Therapy Market: Personalized Cancer Immunotherapy Moves From Concept to Recurrence-Risk Treatment (Last Updated on: June-2026)

The Global Neoantigen Targeted Therapy Market expanding at 28.4% CAGR, growing to USD 8.5 billion b... Read More

Published Date: DEC-2025 | No Of Pages:184 | $ 4485

Theranostics Market By Therapeutic Area (Oncology, Neurology, Cardiology, Others); By Technology Platform (Radiopharmaceuticals, Nanoparticle Systems, Antibody-Drug Conjugates, RNA-Based Platforms); By End User (Academic & Research Institutions, Specialty Clinics, Tertiary Hospitals, CDMOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Theranostics Market growing at 10.4% CAGR, expanding from USD 13.6 billion in 2024 to USD 24.8 billion by 2030, led by precision medicine... Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

Non-Muscle Invasive Bladder Cancer (NMIBC) Market By Therapy Type (Intravesical Therapy, Immuno-Oncology Agents, Surgery & Resection [TURBT], Emerging Therapies); By Route of Administration (Intravesical, Intravenous/Oral); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Non-Muscle Invasive Bladder Cancer (NMIBC) Market is expected to grow steadily at a CAGR of 6.8%, expanding from USD 2.9 billion in 2024 to around USD 4.3 billion ... Read More

Published Date: DEC-2025 | No Of Pages:159 | $ 4485

Cancer Metabolism Based Therapeutics Market By Therapeutic Class (Enzyme Inhibitors, Immunometabolism Modulators, Multi-Pathway Inhibitors); By Cancer Type (Glioblastoma, Pancreatic Cancer, Acute Myeloid Leukemia, Renal Cell Carcinoma, Non-Small Cell Lung Cancer); By Route of Administration (Oral, Intravenous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cancer Metabolism Based Therapeutics Market is expected to grow at a CAGR of 10.8% , reaching a projected value of $6.7 billion by 2030 , up from $3.5 billion in 2... Read More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Functional Endoscopic Sinus Surgery (FESS) Market By Product Type (Endoscopes, Powered Surgical Instruments, Balloon Dilation Systems, Navigation Systems); By Indication (Chronic Rhinosinusitis, Nasal Polyposis, Fungal Sinusitis & Tumors); By End User (Hospitals, ENT Clinics & Specialty Centers, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Functional Endoscopic Sinus Surgery (FESS) Market projected to reach USD 5.2 billion by 2030 from USD 3.5 billion in 2024 at 6.8% CAGR, with key s... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

Allogeneic Cell Therapy Market By Cell Type (Hematopoietic Stem Cells, Mesenchymal Stem Cells, NK Cells, T Cells, Others); By Therapeutic Application (Oncology, Neurology, Autoimmune Disorders, Cardiovascular, Orthopedics, Others); By Source (Bone Marrow, Peripheral Blood, Umbilical Cord Blood, iPSCs); By End User (Hospitals & Specialty Clinics, Academic & Research Institutes, Biopharma & CMOs, Regenerative Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Allogeneic Cell Therapy Market is projected to accelerate at a healthy CAGR of around 18.5%, growing from USD 4.7 billion in 2024 to USD 13.2 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:187 | $ 4485

Novel T-Cell Immunotherapy Market By Therapy Type (CAR-T Cell Therapy, TCR-T Cell Therapy, Tumor-Infiltrating Lymphocytes, Allogeneic T-Cell Therapy); By Indication (Hematologic Malignancies, Solid Tumors, Autoimmune Disorders); By Cell Source (Autologous, Allogeneic); By End User (Academic & Research Institutes, Specialty Cancer Centers, CDMOs, Community Oncology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Novel T-Cell Immunotherapy Market: Approved CAR-T Base Moves Toward TILs, TCR-T, Allogeneic Platforms, and Solid Tumor Expansion (Last Updated on: June-2026)

The Global Novel T-Cell Immunotherapy Market was valued at USD 6.8 billion in 2024 and is projected to re... Read More

Published Date: DEC-2025 | No Of Pages:168 | $ 4485

Vascular Disrupting Agents (VDA) Market By Type of Agent (Tubulin-Binding Agents, Non-Tubulin-Binding Agents); By Cancer Indication (Non-Small Cell Lung Cancer, Ovarian Cancer, Colorectal Cancer, Head and Neck Squamous Cell Carcinoma, Sarcomas); By Route of Administration (Intravenous, Intratumoral); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Vascular Disrupting Agents (VDA) Market is anticipated to expand at a CAGR of 8.5%, moving from USD 1.9 billion in 2024 to nearly USD 3.3 billion by 2030,... Read More

Published Date: DEC-2025 | No Of Pages:164 | $ 4485

DNA Damage Response (DDR) Market By Therapeutic Class (PARP Inhibitors, ATM/ATR Inhibitors, WEE1 Inhibitors, CHK1/CHK2 Inhibitors, POLQ and Others); By Indication (Ovarian Cancer, Breast Cancer, Prostate Cancer, Pancreatic Cancer, Others); By End User (Academic & Research Institutes, Cancer Hospitals, Private Oncology Clinics, Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global DNA Damage Response (DDR) Market is projected to grow steadily, with an estimated value of USD 5.8 billion in 2024 and forecasted to reach USD 11.2 billion by 2030... Read More

Published Date: DEC-2025 | No Of Pages:152 | $ 4485

Peripheral Neuropathy Treatment Market By Treatment Type (Anticonvulsants, Antidepressants, Topical Analgesics, Non-Opioid Sodium-Channel Inhibitors, Opioid Analgesics, Spinal Cord Stimulation Devices, Peripheral Nerve Stimulation Devices, Physical Therapy and Rehabilitation, Nerve-Regeneration Therapies); By Application (Diabetic Peripheral Neuropathy, Chemotherapy-Induced Peripheral Neuropathy, Idiopathic Peripheral Neuropathy, Entrapment and Compression Neuropathy, Drug-Induced Peripheral Neuropathy, Autoimmune and Inflammatory Neuropathy, Nutritional Deficiency-Associated Neuropathy, Hereditary Peripheral Neuropathy); By End User (Hospitals, Neurology Clinics, Pain Management Clinics, Oncology Centers, Diabetes Care Centers, Ambulatory Surgical Centers, Physiotherapy and Rehabilitation Centers, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Peripheral Neuropathy Treatment Market: Refractory Pain and Nerve-Repair Programs Challenge Generic Drug Cycling

The Global Peripheral Neuropathy Treatment Market was valued at USD 2.64 billion in 2025 and is projected to reach USD 4.18 billion by 2032, growing at a C... Read More

Published Date: JUL-2026 | No Of Pages:178 | $ 4485

Joint Pain Injections Market By Product Type (Corticosteroid Injections, Hyaluronic Acid Injections, PRP Injections, Stem Cell-Based Injections, Combination & Other Biologics); By Joint/Application (Knee, Hip, Shoulder, Ankle, Elbow, Others); By End User (Hospitals, Orthopedic Clinics, ASCs, Sports Medicine & Rehab Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Joint Pain Injections Market is projected to grow at a CAGR of 6.8% , reaching approximately USD 8.1 billion in 2030 , up from an estimated USD 5.... Read More

Published Date: DEC-2025 | No Of Pages:190 | $ 4485

Non-Hormonal Contraceptives Market By Product Type (Barrier Methods, Copper IUDs, Spermicides & Vaginal Gels, Fertility Awareness & Digital Tools); By Distribution Channel (Hospitals & Clinics, Retail Pharmacies & Drugstores, Online Platforms); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Non-Hormonal Contraceptives Market is projected to expand steadily between 2024 and 2030, with an estimated valuation of USD 8.7 billion in 2024 and expected to reach arou... Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

TCR Therapy Market By Target Antigen Type (Cancer-Testis Antigens, Neoantigens, Viral Antigens); By Indication (Synovial Sarcoma, Non-Small Cell Lung Cancer, Ovarian Cancer, Colorectal Cancer, Others); By Technology Platform (Naturally Derived TCRs, Affinity-Enhanced TCRs, Gene-Edited TCRs, Allogeneic TCR T cells); By End User (Academic Cancer Centers, Specialized Immunotherapy Clinics, Tertiary Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global TCR Therapy Market will surge at a remarkable CAGR of 38.4%, reaching USD 8.9 billion by 2030 from USD 0.9 billion in 2024, driven by cancer immun... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

Sciatica Treatment Market By Treatment Type (Drug Therapy, Physical Therapy & Rehabilitation, Interventional Procedures, Surgical Interventions, Alternative Therapies); By Route of Administration (Oral, Injectable, Topical, Transdermal); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Pain Clinics, Rehabilitation Centers, Homecare & Digital Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Sciatica Treatment Market is forecast to grow at a steady CAGR of 5.4%, valued at USD 7.8 billion in 2024 and projected to reach nearly USD 10.7 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:162 | $ 4485

Short Bowel Syndrome Market By Drug Class (GLP-2 Analogues, Growth Hormones, Antidiarrheals, Proton Pump Inhibitors, Others); By Route of Administration (Parenteral, Oral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Short Bowel Syndrome Market is anticipated to grow at a CAGR of 8.7 %, valued at USD 1.62 billion in 2024 and projected to reach USD 2.71 billion by 2030,... Read More

Published Date: DEC-2025 | No Of Pages:192 | $ 4485

Neovaginal Surgery Market By Surgical Technique (Penile Inversion, Sigmoid Colon, Peritoneal, Skin/Buccal Graft); By Indication (Gender-Affirming Surgery, Congenital Anomalies, Reconstructive Oncology/Trauma); By End User (Academic Medical Centers, Specialty Clinics, Public Hospitals, Congenital Care Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Neovaginal Surgery Market Is projected to grow at a robust CAGR of 9.8% , reaching a total market value of approximately USD 3.2 billion in 2030 , up from... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

Appendicitis Treatment Market By Treatment Type (Open Appendectomy, Laparoscopic Appendectomy, Robotic-Assisted Appendectomy, Non-Surgical Antibiotic Therapy); By Route of Administration (Intravenous, Oral, Parenteral); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Appendicitis Treatment Market: Antibiotics-First Care Expands Patient Choice While Laparoscopic Surgery Retains the Core Revenue Pool

The Global Appendicitis Treatment Market was estimated to reach USD 4.52 billion in 2025 and is projected to grow to USD 7.55 billion ... Read More

Published Date: JUL-2026 | No Of Pages:153 | $ 4485

Biofilms Treatment Market By Product Type (Topical Agents, Enzymatic Disruptors, Systemic Antibiotics, Surface Coatings, Novel Therapeutics); By Application (Chronic Wounds, Orthopedic Implant Infections, Cardiovascular Devices, Dental & Oral Health, Urology); By End User (Hospitals & Surgical Centers, Wound Care Clinics, Dental Clinics, Veterinary & Military Care); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Biofilms Treatment Market: Procedure Avoidance and Biofilm-Disrupting Combinations Define Commercial Value

The Global Biofilms Treatment Market was valued at USD 3.37 billion in 2025 and is projected to reach USD 6.00 billion by 2032, expanding at an 8.6% CAGR, accord... Read More

Published Date: JUL-2026 | No Of Pages:189 | $ 4485

Leptospirosis Market By Product Type (Diagnostics, Therapeutics, Vaccines); By Application (Human Health, Animal Health); By End User (Hospitals & Clinics, Diagnostic Laboratories, Veterinary Clinics & Farms, Public Health Agencies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Leptospirosis Market is projected to register a CAGR of 5.9%, reaching USD 920 million by 2030 from USD 650 million in 2024, supported by antimicr... Read More

Published Date: DEC-2025 | No Of Pages:193 | $ 4485

Cartilage Degeneration Market By Treatment Type (Non-Surgical [Pharmacological, Biologics, Injections], Surgical [Implants, Grafts, Regenerative Therapies]); By Application (Knee, Hip, Ankle, Shoulder, Others); By End User (Hospitals, Specialty Orthopedic & Sports Medicine Clinics, Ambulatory Surgical Centers, Research & Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cartilage Degeneration Market valued at USD 9.7 billion in 2024 and projected to reach USD 15.3 billion by 2030 at 6.8% CAGR, fueled by cartilage ... Read More

Published Date: DEC-2025 | No Of Pages:154 | $ 4485

Gerontology Market By Product & Service Type (Assistive Technologies, Geriatric Pharmaceuticals, Long-Term Care Services, Digital Health & Monitoring Tools, Wellness & Preventive Services); By Application (Chronic Disease Management, Cognitive Health and Dementia Care, Mobility and Fall Prevention, Mental Health Support, End-of-Life and Palliative Care, Preventive and Lifestyle Medicine); By End User (Hospitals and Geriatric Clinics, Long-Term Care Facilities, Home-Based Care Settings, Community Health Centers, Individual Consumers and Families); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gerontology Market is expected to grow at a robust CAGR of 6.3%, valued at USD 298.7 billion in 2024 and projected to hit USD 455.1 billion by 2030, fuele... Read More

Published Date: DEC-2025 | No Of Pages:153 | $ 4485

Lumpectomy Market By Surgery Type (Standard Lumpectomy, Oncoplastic Lumpectomy, Image-Guided Lumpectomy); By Technology Used (Wire Localization, Radiofrequency & Magnetic Seed Localization, Vacuum-Assisted Excision Devices); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Cancer Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lumpectomy Market is expected to grow at a robust CAGR of 6.1%, with a valuation of USD 2.3 billion in 2024, projected to reach USD 3.3 billionRead More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Dupixent Market By Indication (Atopic Dermatitis, Asthma, Chronic Rhinosinusitis with Nasal Polyps, Eosinophilic Esophagitis, Prurigo Nodularis); By Age Group (Adults, Adolescents, Pediatrics); By Route of Administration (Prefilled Syringes, Auto-injectors); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dupixent Market is forecasted to expand with a CAGR of 13.8%, valued at USD 9.8 billion in 2024, and expected to achieve USD 21.3 billion by 2030<... Read More

Published Date: DEC-2025 | No Of Pages:164 | $ 4485

Lysosomal Storage Disease Treatment Market By Disease Type (Pompe Disease, Gaucher Disease, Fabry Disease, Mucopolysaccharidoses, Niemann-Pick Disease, Metachromatic Leukodystrophy, Acid Sphingomyelinase Deficiency, Krabbe Disease, Batten Disease, Others); By Treatment Type (Enzyme Replacement Therapy, Substrate Reduction Therapy, Pharmacological Chaperones, CNS-Targeted Biologics, Gene Therapy, Hematopoietic Stem Cell Transplantation, Supportive & Disease-Specific Therapies); By Route/Delivery Mode (Intravenous, Oral, Intracerebroventricular/Intrathecal, Ex Vivo Cell-Based Infusion); By Care Setting/Distribution Channel (Hospital & Outpatient Infusion Centers, Specialty Pharmacies, Home Infusion Services, Gene Therapy & Transplant Centers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Lysosomal Storage Disease Treatment Market: Newborn Screening, CNS Delivery, and Gene Therapy Reshape Rare-Disease Treatment

The Global Lysosomal Storage Disease Treatment Market was valued at USD 4.83 billion in 2025 and is projected to reach USD 6.94 billion by 2032... Read More

Published Date: JUL-2026 | No Of Pages:155 | $ 4485

Diabetic Ketoacidosis Treatment Market By Treatment Type (Insulin Therapy, Intravenous Fluids, Electrolyte Replacement, Dextrose Therapy, Subcutaneous Insulin Protocols, Supportive and Complication Management); By Fluid Type (Normal Saline, Balanced Crystalloids, Dextrose-Containing Fluids); By Monitoring Method (Blood Glucose Monitoring, Blood Ketone Monitoring, Electrolyte Testing, Blood Gas Analysis, Continuous Glucose-Ketone Monitoring); By Care Setting (Emergency Department Care, Intensive Care Unit Care, General Ward/Inpatient Care, Ambulatory and Follow-Up Care); By End User (Hospitals, Emergency Care Centers, Specialty Diabetes Clinics, Ambulatory Care Settings); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Diabetic Ketoacidosis Treatment Market Expands Through Hospital Utilization, Intensive Monitoring, and Continuous Ketone Detection

The Global Diabetic Ketoacidosis Treatment Market was valued at USD 912 million in 2025 and is projected to reach USD 1.26 billion by 203... Read More

Published Date: JUL-2026 | No Of Pages:187 | $ 4485

Binge-Eating Disorder Treatment Market By Treatment Type (Psychological & Behavioral Therapy, Pharmacotherapy, Guided Self-Help & Group Therapy, Multidisciplinary Supportive Care); By Care Delivery Model (In-Person Outpatient Care, Telehealth & Virtual Therapy, Hybrid Care Programs, Digital Therapeutic Platforms); By End User (Specialty Eating-Disorder Clinics, Outpatient Therapy Centers, Hospitals & Health Systems, Digital Mental Health Platforms); By Patient Group (Adults With Moderate-to-Severe BED, Patients With Psychiatric Comorbidities, Patients With Obesity & Metabolic Comorbidities, Adolescents); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Binge Eating Disorder Treatment Market: Therapy Access, Generic Competition, and Integrated Care Reshape Treatment Economics

The Global Binge Eating Disorder Treatment Market was valued at USD 716.8 million in 2025 and is projected to reach USD 1.23 billion by 2032, g... Read More

Published Date: JUL-2026 | No Of Pages:157 | $ 4485

Tremfya (Guselkumab) Market By Product Type (Injectable Biologic); By Application (Plaque Psoriasis, Psoriatic Arthritis, Pipeline Indications – Crohn’s Disease, Ulcerative Colitis); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Retail & Specialty Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Tremfya (Guselkumab) Market is forecast to expand at a CAGR of 9.1%, valued at USD 3.1 billion in 2024 and reaching nearly USD 5.8 billion by 2030, driven... Read More

Published Date: DEC-2025 | No Of Pages:196 | $ 4485

Naltrexone and Buprenorphine Market By Product Type (Naltrexone, Buprenorphine); By Route of Administration (Oral, Transdermal/Implants, Injectables); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Naltrexone and Buprenorphine Market will witness a steady CAGR of 6.8% , valued at around USD 3.6 billion in 2024 , and projected to reach USD 5.4 billion by 2030<... Read More

Published Date: DEC-2025 | No Of Pages:186 | $ 4485

Cyclosporine Market By Therapeutic Application (Transplantation, Autoimmune Disorders, Ophthalmology); By Formulation Type (Oral Capsules, Injectables, Topical Formulations); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cyclosporine Market will see consistent expansion at a CAGR of 6.1%, rising from USD 1.53 billion in 2024 to USD 2.19 billion by 2030, supported by strong... Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

Thoracic Aortic Aneurysm Market By Product Type (Stent Grafts, Synthetic Grafts, Surgical Instruments, Imaging Systems); By Approach (Endovascular Repair [TEVAR], Open Surgical Repair); By Indication (Ascending Aortic Aneurysms, Descending Thoracic Aneurysms, Thoracoabdominal Aneurysms); By End User (Hospitals, Specialty Cardiac Centers, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Thoracic Aortic Aneurysm Market is set to witness stable expansion at a CAGR of 8.4%, increasing from USD 2.5 billion in 2024 to USD 4.1 billion by 2030, ... Read More

Published Date: DEC-2025 | No Of Pages:177 | $ 4485

Anti-Biofilm Wound Dressing Market By Product Type (Foam Dressings, Hydrofiber Dressings, Alginate Dressings, Combination Dressings); By Wound Type (Chronic Wounds, Acute Wounds); By End User (Hospitals, Specialty Wound Care Clinics, Ambulatory Surgical Centers, Home Healthcare, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Anti-Biofilm Wound Dressing Market is set to grow at a sustained CAGR of 6%, climbing from USD 790 million in 2024 to more than USD 1.1 billion by 2030, p... Read More

Published Date: DEC-2025 | No Of Pages:193 | $ 4485

Male Urinary Incontinence Market By Product Type (Catheters, Artificial Urinary Sphincters, Male Slings, Absorbent Products, External Clamps); By Application (Stress Incontinence, Urge Incontinence, Overflow Incontinence, Mixed Incontinence); By End User (Hospitals, Specialty Urology Clinics, Ambulatory Surgical Centers, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Male Urinary Incontinence Market will witness a CAGR of 6.8%, valued at USD 3.4 billion in 2024, expected to reach nearly USD 5.1 billion by 2030, driven ... Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

Recombinant Human Endostatin Market By Product Type (Therapeutic-Grade Recombinant Human Endostatin Injection, Research-Grade Recombinant Human Endostatin Protein); By Application (Advanced and Metastatic Non-Small Cell Lung Cancer, Malignant Pleural and Thoracoabdominal Effusion, Other Solid Tumors, Angiogenesis and Endothelial-Cell Research); By End User (Hospitals and Oncology Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Preclinical and Laboratory Research Facilities); By Distribution Channel (Hospital Procurement and Reimbursement Channels, Direct Research Supply, Laboratory Product Distributors); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Recombinant Human Endostatin Market - China-Centered Therapeutic Demand Defines the Market

The Global Recombinant Human Endostatin Market was valued at USD 0.158 billion in 2025 and is projected to reach USD 0.278 billion by 2032, exp... Read More

Published Date: Aug-2026 | No Of Pages:199 | $ 4485

Hemangioma Treatment Market By Therapy Type (Pharmacological Therapy, Laser Therapy, Surgical and Interventional Approaches); By Application (Cutaneous Hemangiomas, Visceral Hemangiomas, Mixed and Complicated Hemangiomas); By End User (Hospitals, Specialty Dermatology and Pediatric Clinics, Ambulatory Surgical Centers, Community Health Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hemangioma Treatment Market will grow at a CAGR of 6.8% , valued at USD 4.9 billion in 2024 , and projected to reach USD 7.7 bill... Read More

Published Date: DEC-2025 | No Of Pages:197 | $ 4485